10.0TWD
1.45 BTWD
10.63 BTWD
120.77 M
About GRAPE KING BIO LTD
Sector
CEO
Sheng Lin Tseng
Headquarters
Taoyuan
Website
Founded
1971
ISIN
TW0001707008
FIGI
BBG000BDB8Y1
Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. It operates through the following segments: Multi-Level Marketing (MLM), Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM). The MLM segment is involved in the direct seller of Pro-partner Inc., including the company’s development and manufacturing products for Pro-partner Inc., The Distributors segment include GRAPE KING BIO’s self-owned brand products. The ODM/OEM segment refers to the ODM/OEM in Taiwan and Shanghai. The company was founded by Shui Chao Tseng on April 1, 1971 and is headquartered in Taoyuan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1707 is 159.0 TWD — it has increased by 1.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange GRAPE KING BIO LTD stocks are traded under the ticker 1707.
GRAPE KING BIO LTD is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
1707 stock is 2.90% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is GRAPE KING BIO LTD there?
One year price forecast for GRAPE KING BIO LTD has a max estimate of 196.0 TWD and a min estimate of 161.0 TWD.
1707 earnings for the last quarter are 2.48 TWD whereas the estimation was 2.45 TWD which accounts for 1.09% surprise. Estimated earnings for the next quarter are 3.33 TWD. See more details about GRAPE KING BIO LTD earnings.
GRAPE KING BIO LTD revenue for the last quarter amounts to 2.55 B TWD despite the estimated figure of 2.68 B TWD. In the next quarter revenue is expected to reach 3.27 B TWD.
Yes, you can track GRAPE KING BIO LTD financials in yearly and quarterly reports right on TradingView.
1707 stock has fallen by 1.24% compared to the previous week, the month change is a 2.25% rise, over the last year GRAPE KING BIO LTD has showed a 15.87% decrease.
1707 net income for the last quarter is 468.33 M TWD, while the quarter before that showed 366.74 M TWD of net income which accounts for 27.70% change. Track more GRAPE KING BIO LTD financial stats to get the full picture.
Today GRAPE KING BIO LTD has the market capitalization of 23.18 B, it has increased by 0.31% over the last week.
Yes, 1707 dividends are paid annually. The last dividend per share was 6.90 TWD. As of today, Dividend Yield (TTM)% is 4.41%. Tracking GRAPE KING BIO LTD dividends might help you take more informed decisions.
GRAPE KING BIO LTD dividend yield was 4.42% in 2023, and payout ratio reached 70.36%. The year before the numbers were 4.11% and 70.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1707 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAPE KING BIO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAPE KING BIO LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAPE KING BIO LTD stock shows the sell signal. See more of GRAPE KING BIO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GRAPE KING BIO LTD future price: according to them, 1707 price has a max estimate of 196.00 TWD and a min estimate of 161.00 TWD. Read a more detailed GRAPE KING BIO LTD forecast: see what analysts think of GRAPE KING BIO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAPE KING BIO LTD EBITDA is 2.95 B TWD, and current EBITDA margin is 27.73%. See more stats in GRAPE KING BIO LTD financial statements.